Isoray, Inc. (ISR)

$0.339

+0.06 (+22.43%)
Rating:
Recommendation:
Buy
Symbol ISR
Price $0.339
Beta 0.871
Volume Avg. 0.27M
Market Cap 48.176M
Shares () -
52 Week Range 0.19-0.69
1y Target Est -
DCF Unlevered ISR DCF ->
DCF Levered ISR LDCF ->
ROE -11.42% Sell
ROA -11.29% Sell
Operating Margin -
Debt / Equity 5.16% Neutral
P/E -
P/B 0.79 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ISR news


Ms. Lori Woods
Healthcare
Medical Devices
American Stock Exchange

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.